-
2025 ICML | Prof. : Insights from the EBMT Lymphoma Working Party—What’s Driving Better Transplant Outcomes?
Oncology Frontier – Hematology Frontier: Based on EBMT data, what are the core drivers behind the improved transplant outcomes for relapsed Hodgkin lymphoma in the past decade? How much of…
-
Wenyu Shi: Latest Advances in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis (HLH) | 2025 Hematology Translational and Innovation Conference
As vibrant blossoms filled the streets of Shanghai and the Huangpu River shimmered beneath the morning sun, the 2025 Hematology Translational and Innovation Conference, held in parallel with the 10th Shanghai Lymphoid Disease Symposium, was convened from June 27 to 29. This prominent academic event brought together leading experts from China and abroad to share…
-
Wenbin Qian: Latest Advances in CAR-NK Cell Therapy for Lymphoma | 2025 Hematology Translational and Innovation Conference
As summer bloomed in Shanghai and the tide of the Huangpu River caught the morning light, the 2025 Hematology Translational and Innovation Conference, held in parallel with the 10th Shanghai Lymphoid Disease Symposium, took place from June 27 to 29. This major academic event welcomed prominent experts from China and abroad to share cutting-edge achievements,…
-
CAH 2025 | Professor Jin Lu: Advancing High-Quality Development in Multiple Myeloma Care through Standardized Treatment, Data Integration, and Optimized Follow-up
From June 20 to 22, the 19th Annual Meeting of the Chinese Medical Doctor Association Hematology Branch and the 2025 China Hematology Conference (CAH 2025) was held in the historic city of Xi’an. As a major academic event in China’s hematology community, the conference maintained its core mission of “serving clinical practice,” with a strong…
-
CAH 2025 | Professor Lei Fan: Advancing a Paradigm Shift in the Treatment of Indolent Lymphoma and Exploring a China-Specific Model for Lifelong Disease Management
In early summer, the historic city of Xi’an welcomed a gathering of leading experts at the 19th Annual Meeting of the Chinese Association of Hematologists and the 2025 China Annual Hematology Conference (CAH 2025), held from June 20 to 22. The event was co-hosted by the Chinese Medical Doctor Association and its Hematology Branch, in…
-
Prof. Yao Zhu: A “Prevention-Treatment-Research” Integrated Approach to Prostate Cancer Management | 2025 Pujiang Prostate Cancer Conference
The “2025 Pujiang Prostate Cancer Academic Conference,” held from June 27 to 28 in Shanghai, was jointly organized with the Annual Meeting of the Chinese Society of Clinical Oncology Prostate Cancer Committee (CSCO-PC), the Chinese Anti-Cancer Association Genitourinary Oncology (CACA-GO) Prostate Cancer Conference, and the Chinese Prostate Cancer Consortium (CPCC) Annual Meeting. Themed “Global Wisdom…
-
Qiang Wei, MD, PhD: Escalation and De-escalation Strategies in mHSPC Treatment
The 2025 Pujiang Prostate Cancer Academic Conference—held from June 27 to 28 in Shanghai—was jointly hosted by the Chinese Society of Clinical Oncology Prostate Cancer Committee (CSCO-PC), the Chinese Anti-Cancer Association Genitourinary Oncology Committee (CACA-GO), and the China Prostate Cancer Consortium (CPCC). With the theme “Global Wisdom, Chinese Practice, and Precision Breakthroughs,” the conference brought…
-
Professor Xudong Yao: The “Shanghai Tenth Hospital Experience” in Prostate Cancer Diagnosis, Treatment, and Research2025 Pujiang Prostate Cancer Conference
The “2025 Pujiang Prostate Cancer Academic Conference,” held in Shanghai from June 27 to 28, was jointly hosted alongside the Annual Meeting of the Chinese Society of Clinical Oncology Prostate Cancer Committee (CSCO-PC), the Prostate Cancer Subcommittee of the Chinese Anti-Cancer Association (CACA-GO), and the Chinese Prostate Cancer Consortium (CPCC). With the theme “Global Wisdom,…
Connecting Medical Expertise through Media